OncoLeap Therapeutics Revenue

Biotechnology Research • Montreal, Quebec, Canada • 1-10 Employees

OncoLeap Therapeutics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at OncoLeap Therapeutics

Dilan B. Jaunky

Co-Founder

Company overview

Headquarters	Montreal, Quebec, Canada
Websites	oncoleap.com oncoleap.ca
NAICS	541714
Keywords	Molecular Biology, Drug Development, Medicinal Chemistry, Cancer Therapeutics, Targeted Therapies, Cell Division
Founded	2023
Employees	1-10

About OncoLeap Therapeutics

At OncoLeap Therapeutics Inc, we strive to develop better therapies for cancer patients using our novel family of compounds. We see cancer therapeutics as a growing arsenal of treatments against the disease, which ultimately provides new options for patients.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

OncoLeap Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

OncoLeap Therapeutics has never raised funding before.

OncoLeap Therapeutics Tech Stack

Discover the technologies and tools that power OncoLeap Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

LiteSpeed

Web servers

HTTP/3

Miscellaneous

FancyBox

JavaScript libraries

Hostinger

Hosting

Bootstrap

UI frameworks

jQuery UI

JavaScript libraries

Popper

Miscellaneous

Google Font API

Font scripts

Frequently asked questions

OncoLeap Therapeutics is located in Montreal, Quebec, CA.

OncoLeap Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

OncoLeap Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

OncoLeap Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

OncoLeap Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at OncoLeap Therapeutics

Dilan B. Jaunky

Co-Founder

4.8

40,000 users